Azitra, Inc.
@azitrainc
Precision dermatology powered by microbial and genetic engineering
Developing novel therapeutics to treat adverse skin conditions and disease
ID: 4164192988
http://www.azitrainc.com 11-11-2015 13:43:30
415 Tweet
534 Takipçi
381 Takip Edilen
Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference - more details available here $AZTR ir.azitrainc.com/news-releases/…
Last week we announced that the first patient had been dosed in our Ph1/2 Trial for our ATR-04 Program targeting #oncology patients with #EGFRiRash. For more info on the trial - Check out this article from CancerNetwork® cancernetwork.com/view/advancing…
Reminder that Azitra, Inc. Cofounder and Chief Operating Officer, Travis Whitfill PhD MPH, delivered a virtual presentation at the H.C. Wainwright 27th Annual Global Investment Conference Registration info: journey.ct.events/view/d825c56c-… #biotech #HCWainwright #PrecisionDerm
Azitra, Inc. - Developing a broad pipeline of precision dermatology products. Learn about our #pipeline here azitrainc.com/pipeline/ #biotech #NethertonSyndrome #EGFRirash #Dermatology #PrecisionDerm #IchthyosisVulgaris
About us: Azitra, Inc. is leveraging microbial & protein engineering to solve the challenges of skin diseases through 3 strategies: -Proprietary microbial library -Engineering microbes for drug delivery -Advance genetic engineering Learn more: azitrainc.com/technology/ $AZTR
Azitra, Inc. to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit - #biotech #RareDisease #Dermatology #PrecisionDerm Maxim Group LLC $AZTR prnewswire.com/news-releases/…
Yesterday's announcement in case you missed it - Azitra, Inc. to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit - #biotech #RareDisease #Dermatology #PrecisionDerm Maxim Group LLC $AZTR More info here: ir.azitrainc.com/news-releases/…
Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris ir.azitrainc.com/news-releases/… Data to be presented at BIO-Europe! #biotech #RareDisease #Derm #Dermatology #PrecisionDerm #IchthyosisVulgaris #BIOEurope $AZTR
Great coverage in Dermatology Times highlighting our ATR-01 program in ichthyosis vulgaris! dermatologytimes.com/view/azitra-s-… #biotech #RareDisease #Derm #IchthyosisVulgaris #BIOEurope $AZTR
Last week, we announced positive preclinical progress for our ATR-01 ichthyosis vulgaris program. For more info about this rare skin condition, see the Foundation for Ichthyosis and Related Skin Types (FIRST) firstskinfoundation.org/types-of-ichth… #RareDisease #Dermatology #IchthyosisVulgaris
More from our most recent announcement. Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris. Read the release here: ir.azitrainc.com/news-releases/… #RareDisease #Dermatology #IchthyosisVulgaris $AZTR
Azitra, Inc. Addresses False Report Regarding Sale of Securities - Azitra, Inc. $AZTR ir.azitrainc.com/news-releases/…
Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates #biotech #PrecisionMedicine #PrecisionDerm #ClinicalTrials #NethertonSyndrome #EGFRiRash #CancerRash #IchthyosisVulgaris ir.azitrainc.com/news-releases/…